Join
Live feed
·
PRReleasevia Quantisnow
Generate Biomedicines Inc. logo
Zealand Pharma A/S logo

Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GENB (Generate Biomedicines Inc.), ZEAL (Zealand Pharma A/S) and more on Quantisnow.